Literature DB >> 29883244

A microfluidic competitive immuno-aggregation assay for high sensitivity cell secretome detection.

Fan Liu1, Pawan Kc2, Liwei Ni1, Ge Zhang2, Jiang Zhe1.   

Abstract

We report a high-sensitivity cell secretome detection method using competitive immuno-aggregation and a micro-Coulter counter. A target cell secretome protein competes with anti-biotin-coated microparticles (MPs) to bind with a biotinylated antibody (Ab), causing decreased aggregation of the functionalized MPs and formation of a mixture of MPs and aggregates. In comparison, without the target cell secretome protein, more microparticles are functionalized, and more aggregates are formed. Thus, a decrease in the average volume of functionalized microparticles/aggregates indicates an increase in cell secretome concentration. This volume change is measured by the micro-Coulter counter, which is used to quantitatively estimate the cell secretome concentration. Vascular endothelial growth factor (VEGF), one of the key cell secretome proteins that regulate angiogenesis and vascular permeabilization, was used as the target protein to demonstrate the sensing principle. A standard calibration curve was generated by testing samples with various VEGF concentrations. A detection range from 0.01 ng/mL to 100.00 ng/mL was achieved. We further demonstrated the quantification of VEGF concentration in exogenous samples collected from the secretome of human mesenchymal stem cells (hMSCs) at different incubation times. The results from the assay agree well with the results of a parallel enzyme-linked immunoabsorbent assay (ELISA) test, indicating the specificity and reliability of the competitive immuno-aggregation assay. With its simple structure and easy sample preparation, this assay not only enables high sensitivity detection of VEGF but also can be readily extended to other types of cell secretome analysis as long as the specific Ab is known.

Entities:  

Keywords:  Microfluidic; cell secretome; competitive immuno-aggregation; functionalized microparticle; vascular endothelial growth factor

Mesh:

Substances:

Year:  2018        PMID: 29883244      PMCID: PMC6150055          DOI: 10.1080/15476278.2018.1461306

Source DB:  PubMed          Journal:  Organogenesis        ISSN: 1547-6278            Impact factor:   2.500


  62 in total

1.  A high-capacity streptavidin-coated microtitration plate.

Authors:  Lasse Välimaa; Kim Pettersson; Markus Vehniäinen; Matti Karp; Timo Lövgren
Journal:  Bioconjug Chem       Date:  2003 Jan-Feb       Impact factor: 4.774

2.  Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways.

Authors:  K P Claffey; W O Wilkison; B M Spiegelman
Journal:  J Biol Chem       Date:  1992-08-15       Impact factor: 5.157

3.  Binding of biotinylated DNA to streptavidin-coated polystyrene latex: effects of chain length and particle size.

Authors:  S C Huang; M D Stump; R Weiss; K D Caldwell
Journal:  Anal Biochem       Date:  1996-05-15       Impact factor: 3.365

4.  Profiling of the human monocytic cell secretome by quantitative label-free mass spectrometry identifies stimulus-specific cytokines and proinflammatory proteins.

Authors:  M Groessl; H Luksch; A Rösen-Wolff; A Shevchenko; M Gentzel
Journal:  Proteomics       Date:  2012-09       Impact factor: 3.984

5.  Vascular endothelial growth factor (VEGF) and prostate pathology.

Authors:  Francisco Botelho; Francisco Pina; Pedro Silva; Gabriela Figueiredo; Francisco Cruz; Nuno Lunet
Journal:  Int Braz J Urol       Date:  2010 Jul-Aug       Impact factor: 1.541

Review 6.  Lessons from phase III clinical trials on anti-VEGF therapy for cancer.

Authors:  Rakesh K Jain; Dan G Duda; Jeffrey W Clark; Jay S Loeffler
Journal:  Nat Clin Pract Oncol       Date:  2006-01

7.  LY317615 decreases plasma VEGF levels in human tumor xenograft-bearing mice.

Authors:  Kristan A Keyes; Larry Mann; Michael Sherman; Elizabeth Galbreath; Linda Schirtzinger; Darryl Ballard; Yun-Fei Chen; Philip Iversen; Beverly A Teicher
Journal:  Cancer Chemother Pharmacol       Date:  2003-10-31       Impact factor: 3.333

8.  Detection and Quantification of VEGF Isoforms by ELISA.

Authors:  Jean-Michel Vernes; Y Gloria Meng
Journal:  Methods Mol Biol       Date:  2015

9.  Biologic implications of the expression of vascular endothelial growth factor subtypes in ovarian carcinoma.

Authors:  J Fujimoto; H Sakaguchi; R Hirose; S Ichigo; T Tamaya
Journal:  Cancer       Date:  1998-12-15       Impact factor: 6.860

10.  VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism.

Authors:  Hans-Peter Gerber; Ajay K Malik; Gregg P Solar; Daniel Sherman; Xiao Huan Liang; Gloria Meng; Kyu Hong; James C Marsters; Napoleone Ferrara
Journal:  Nature       Date:  2002-06-27       Impact factor: 49.962

View more
  1 in total

Review 1.  Microfluidics for Peptidomics, Proteomics, and Cell Analysis.

Authors:  Rui Vitorino; Sofia Guedes; João Pinto da Costa; Václav Kašička
Journal:  Nanomaterials (Basel)       Date:  2021-04-26       Impact factor: 5.076

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.